Putting genome data into the public domain advances science, but nearly all of it can be linked to someone.
Antonio RegaladoFollow @twitterapi
Senior Editor, Business
I am the business editor of MIT Technology Review. I look for stories about how technology is changing business. Before joining MIT Technology Review in July 2011, I lived in São Paulo, Brazil, where I wrote about science, technology, and politics in Latin America for Science and other publications. From 2000 to 2009, I was the science reporter at the Wall Street Journal and later a foreign correspondent.
Antonio Regalado's Stories
By reviving lost species, a new company could put a warm and fuzzy face on advanced reproductive engineering.
Getting you to take your eyes off the road could be worth billions in new search revenue to Google.
A Russian mogul uses a science award to spread Internet millions among university biologists. Is he after a cure for cancer?
A leading neuroscientist says Kurzweil’s Singularity isn’t going to happen. Instead, humans will assimilate machines.
Did Obama’s State of the Union speech include more mentions of technology than any other president’s?
A patent that covers digital encryption of "objects" could bring copy protection to 3-D printing.
A prominent venture capital fund—Union Square Ventures—reckons so, but it adds that academic credentials will also remain vital.